Match tier Likely match
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Brian Delavan

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

Also affiliated: United States Food and Drug Administration (2017–2020)

Faculty Researcher

5 h-index 7 pubs 244 cited

  • Animals
  • Humans
  • Antineoplastic Agents
  • Drug Screening Assays, Antitumor
  • Neoplasms
  • Xenograft Model Antitumor Assays
  • Cell Line, Tumor
  • Drug Discovery
  • Translational Research, Biomedical
  • Pharmaceutical Preparations
  • Genome, Human
  • Computational Biology
  • Genomics
  • Rare Diseases
  • Precision Medicine

Biography and Research Information

OverviewAI-generated summary

Brian Delavan's research focuses on the intersection of bioinformatics and public health, with a recent publication exploring its application in tuberculosis surveillance. His work involves studying disease patterns and developing new approaches to combat ancient threats. Delavan's scholarship metrics include an h-index of 5, with a total of 7 publications cited 235 times. He collaborates with David W. Ussery from the University of Arkansas for Medical Sciences, with whom he shares one publication. Delavan's recent activity indicates ongoing engagement in his research areas.

Metrics

  • h-index: 5
  • Publications: 7
  • Citations: 244

Selected Publications

  • Bioinformatics into TB surveillance: A new approach to an ancient foe (2025)
    Open Access Government DOI OpenAlex
  • Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach (2020)
    Frontiers in Pharmacology 11 citations DOI OpenAlex
  • A Pair Ranking (PRank) Method for Assessing Assay Transferability Among the Toxicogenomics Testing Systems (2019)
    Challenges and advances in computational chemistry and physics DOI OpenAlex
  • Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management (2018)
    Drug Discovery Today 39 citations DOI OpenAlex
  • Transcriptional Responses Reveal Similarities Between Preclinical Rat Liver Testing Systems (2018)
    Frontiers in Genetics 10 citations DOI OpenAlex
  • Computational drug repositioning for rare diseases in the era of precision medicine (2017)
    Drug Discovery Today 89 citations DOI OpenAlex
  • Lessons Learned from Two Decades of Anticancer Drugs (2017)
    Trends in Pharmacological Sciences 95 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

1 Collaborator 1 Institution 1 Country

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics